Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

3.280 -0.120 (-3.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,100
Open 3.410
Bid (Size) 3.100 (3)
Ask (Size) 3.380 (7)
Prev. Close 3.400
Today's Range 3.230 - 3.450
52wk Range 3.030 - 9.329
Shares Outstanding 16,440,036
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-53.8%
-53.8%
1 Month
+2.5%
+2.5%
3 Month
-21.2%
-21.2%
6 Month
-28.9%
-28.9%
1 Year
-48.1%
-48.1%

More News

Read More
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
From Sensus Healthcare, Inc.
Via Business Wire
Earnings Scheduled For August 7, 2025
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Sensus (SRTS) Q2 Revenue Falls 21%
Via The Motley Fool
Topics Economy Intellectual Property
Sensus Healthcare Reports Second Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
From Sensus Healthcare, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
From Sensus Healthcare, Inc.
Via Business Wire

Frequently Asked Questions

Is Sensus Healthcare, Inc. - Common Stock publicly traded?
Yes, Sensus Healthcare, Inc. - Common Stock is publicly traded.
What exchange does Sensus Healthcare, Inc. - Common Stock trade on?
Sensus Healthcare, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sensus Healthcare, Inc. - Common Stock?
The ticker symbol for Sensus Healthcare, Inc. - Common Stock is SRTS on the Nasdaq Stock Market
What is the current price of Sensus Healthcare, Inc. - Common Stock?
The current price of Sensus Healthcare, Inc. - Common Stock is 3.280
When was Sensus Healthcare, Inc. - Common Stock last traded?
The last trade of Sensus Healthcare, Inc. - Common Stock was at 10/10/25 04:00 PM ET
What is the market capitalization of Sensus Healthcare, Inc. - Common Stock?
The market capitalization of Sensus Healthcare, Inc. - Common Stock is 53.92M
How many shares of Sensus Healthcare, Inc. - Common Stock are outstanding?
Sensus Healthcare, Inc. - Common Stock has 54M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.